Medrio’s Acquisition of HMD Clinical

Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP advised Medrio on the deal.

Medrio, a leading provider of eClinical technology to pharmaceutical, biotech, medical device, diagnostics, and animal health markets, announced its acquisition of HMD Clinical. The acquisition will enable Medrio to expand its portfolio of proven eClinical technology solutions and integrate HMD’s expertise in Randomization and Trial Supply Management (RTSM) with Medrio’s expertise in electronic data capture.

The Gunderson deal team was led by Matthew Martinez (Picture) and included Bennett Yee, Nicholas Markman and Amy Luong.

Involved fees earner: Amy Luong – Gunderson Dettmer; Nicholas Markman – Gunderson Dettmer; Matthew Martinez – Gunderson Dettmer; Bennett Yee – Gunderson Dettmer;

Law Firms: Gunderson Dettmer;

Clients: Medrio;

Print Friendly, PDF & Email
Martina Bellini

Author: Martina Bellini